메뉴 건너뛰기




Volumn 35, Issue 5, 2015, Pages 421-431

EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index

Author keywords

CDKN2A; EZH2; Gliomas; p16

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; PROTEIN P16; TRANSCRIPTION FACTOR EZH2; EZH2 PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2;

EID: 84942834914     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12201     Document Type: Article
Times cited : (20)

References (42)
  • 1
    • 33750379420 scopus 로고    scopus 로고
    • Polycomb silencers control cell fate, development and cancer
    • Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006; 6: 846-856.
    • (2006) Nat Rev Cancer , vol.6 , pp. 846-856
    • Sparmann, A.1    van Lohuizen, M.2
  • 2
    • 67649397334 scopus 로고    scopus 로고
    • Epigenetic gene regulation in stem cells and correlation to cancer
    • Mathews LA, Crea F, Farrar WL. Epigenetic gene regulation in stem cells and correlation to cancer. Differentiation 2009; 78: 1-17.
    • (2009) Differentiation , vol.78 , pp. 1-17
    • Mathews, L.A.1    Crea, F.2    Farrar, W.L.3
  • 3
    • 84868016543 scopus 로고    scopus 로고
    • EZH2: a pivotal regulator in controlling cell differentiation
    • Chen YH, Hung MC, Li LY. EZH2: a pivotal regulator in controlling cell differentiation. Am J Transl Res 2012; 4: 364-375.
    • (2012) Am J Transl Res , vol.4 , pp. 364-375
    • Chen, Y.H.1    Hung, M.C.2    Li, L.Y.3
  • 4
    • 79955513100 scopus 로고    scopus 로고
    • Aberrations of EZH2 in cancer
    • Chase A, Cross NC. Aberrations of EZH2 in cancer. Clin Cancer Res 2011; 17: 2613-2618.
    • (2011) Clin Cancer Res , vol.17 , pp. 2613-2618
    • Chase, A.1    Cross, N.C.2
  • 5
    • 0035877978 scopus 로고    scopus 로고
    • Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
    • van Kemenade FJ, Raaphorst FM, Blokzijl T etal. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001; 97: 3896-3901.
    • (2001) Blood , vol.97 , pp. 3896-3901
    • van Kemenade, F.J.1    Raaphorst, F.M.2    Blokzijl, T.3
  • 6
    • 0141816752 scopus 로고    scopus 로고
    • EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
    • Kleer CG, Cao Q, Varambally S etal. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003; 100: 11606-11611.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 11606-11611
    • Kleer, C.G.1    Cao, Q.2    Varambally, S.3
  • 7
    • 9144226103 scopus 로고    scopus 로고
    • Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene
    • Raaphorst FM, Meijer CJ, Fieret E etal. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. Neoplasia 2003; 5: 481-488.
    • (2003) Neoplasia , vol.5 , pp. 481-488
    • Raaphorst, F.M.1    Meijer, C.J.2    Fieret, E.3
  • 8
    • 34250706864 scopus 로고    scopus 로고
    • Polycomb-group oncogenes EZH2, BMI1,and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features
    • van Leenders GJ, Dukers D, Hessels D etal. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur Urol 2007; 52: 455-463.
    • (2007) Eur Urol , vol.52 , pp. 455-463
    • van Leenders, G.J.1    Dukers, D.2    Hessels, D.3
  • 9
    • 18644382388 scopus 로고    scopus 로고
    • The polycomb group protein EZH2 is involved in progression of prostate cancer
    • Varambally S, Dhanasekaran SM, Zhou M etal. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624-629.
    • (2002) Nature , vol.419 , pp. 624-629
    • Varambally, S.1    Dhanasekaran, S.M.2    Zhou, M.3
  • 11
    • 29344445843 scopus 로고    scopus 로고
    • Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
    • Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res 2005; 11: 8570-8576.
    • (2005) Clin Cancer Res , vol.11 , pp. 8570-8576
    • Raman, J.D.1    Mongan, N.P.2    Tickoo, S.K.3    Boorjian, S.A.4    Scherr, D.S.5    Gudas, L.J.6
  • 12
    • 29344439946 scopus 로고    scopus 로고
    • Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas
    • Weikert S, Christoph F, Köllermann J etal. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med 2005; 16: 349-353.
    • (2005) Int J Mol Med , vol.16 , pp. 349-353
    • Weikert, S.1    Christoph, F.2    Köllermann, J.3
  • 13
    • 33744519651 scopus 로고    scopus 로고
    • Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer
    • Matsukawa Y, Semba S, Kato H, Ito A, Yanagihara K, Yokozaki H. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci 2006; 97: 484-491.
    • (2006) Cancer Sci , vol.97 , pp. 484-491
    • Matsukawa, Y.1    Semba, S.2    Kato, H.3    Ito, A.4    Yanagihara, K.5    Yokozaki, H.6
  • 14
    • 56649103900 scopus 로고    scopus 로고
    • Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells
    • Watanabe H, Soejima K, Yasuda H etal. Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 2008; 8: 15. doi: 10.1186/1475-2867-8-15.
    • (2008) Cancer Cell Int , vol.8 , pp. 15
    • Watanabe, H.1    Soejima, K.2    Yasuda, H.3
  • 15
    • 19944397508 scopus 로고    scopus 로고
    • Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma
    • Sudo T, Utsunomiya T, Mimori K etal. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer 2005; 92: 1754-1758.
    • (2005) Br J Cancer , vol.92 , pp. 1754-1758
    • Sudo, T.1    Utsunomiya, T.2    Mimori, K.3
  • 16
    • 24744464786 scopus 로고    scopus 로고
    • Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
    • Takeshita F, Minakuchi Y, Nagahara S etal. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci U S A 2005; 102: 12177-12182.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 12177-12182
    • Takeshita, F.1    Minakuchi, Y.2    Nagahara, S.3
  • 17
    • 35748937338 scopus 로고    scopus 로고
    • Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer
    • Yu J, Cao Q, Mehra R etal. Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell 2007; 12: 419-431.
    • (2007) Cancer Cell , vol.12 , pp. 419-431
    • Yu, J.1    Cao, Q.2    Mehra, R.3
  • 18
    • 79957568143 scopus 로고    scopus 로고
    • miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
    • Smits M, Nilsson J, Mir SE etal. miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 2010; 1: 710-720.
    • (2010) Oncotarget , vol.1 , pp. 710-720
    • Smits, M.1    Nilsson, J.2    Mir, S.E.3
  • 19
    • 84867509134 scopus 로고    scopus 로고
    • Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase
    • Ott M, Litzenburger UM, Sahm F etal. Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase. PLoS ONE 2012; 7: e47663.
    • (2012) PLoS ONE , vol.7 , pp. e47663
    • Ott, M.1    Litzenburger, U.M.2    Sahm, F.3
  • 20
    • 84856466661 scopus 로고    scopus 로고
    • The role of EZH2 in tumour progression
    • Chang CJ, Hung MC. The role of EZH2 in tumour progression. Br J Cancer 2012; 106: 243-247.
    • (2012) Br J Cancer , vol.106 , pp. 243-247
    • Chang, C.J.1    Hung, M.C.2
  • 21
    • 0028986612 scopus 로고
    • Loss of P16INK4 expression is frequent in high grade gliomas
    • Nishikawa R, Furnari FB, Lin H etal. Loss of P16INK4 expression is frequent in high grade gliomas. Cancer Res 1995; 55: 1941-1945.
    • (1995) Cancer Res , vol.55 , pp. 1941-1945
    • Nishikawa, R.1    Furnari, F.B.2    Lin, H.3
  • 22
    • 0029823960 scopus 로고    scopus 로고
    • Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices
    • Ono Y, Tamiya T, Ichikawa T etal. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neurol 1996; 55: 1026-1031.
    • (1996) J Neuropathol Exp Neurol , vol.55 , pp. 1026-1031
    • Ono, Y.1    Tamiya, T.2    Ichikawa, T.3
  • 23
    • 0032947770 scopus 로고    scopus 로고
    • CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas
    • Miettinen H, Kononen J, Sallinen P etal. CDKN2/p16 predicts survival in oligodendrogliomas: comparison with astrocytomas. J Neurooncol 1999; 41: 205-211.
    • (1999) J Neurooncol , vol.41 , pp. 205-211
    • Miettinen, H.1    Kononen, J.2    Sallinen, P.3
  • 24
    • 84877107135 scopus 로고    scopus 로고
    • EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells
    • Zhong J, Min L, Huang H etal. EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells. Technol Cancer Res Treat 2013; 12: 269-274.
    • (2013) Technol Cancer Res Treat , vol.12 , pp. 269-274
    • Zhong, J.1    Min, L.2    Huang, H.3
  • 25
    • 69349093771 scopus 로고    scopus 로고
    • Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin
    • Yamaguchi J, Sasaki M, Harada K etal. Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin. Lab Invest 2009; 89: 1018-1031.
    • (2009) Lab Invest , vol.89 , pp. 1018-1031
    • Yamaguchi, J.1    Sasaki, M.2    Harada, K.3
  • 26
    • 33846148370 scopus 로고    scopus 로고
    • pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene
    • Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 2007; 21: 49-54.
    • (2007) Genes Dev , vol.21 , pp. 49-54
    • Kotake, Y.1    Cao, R.2    Viatour, P.3    Sage, J.4    Zhang, Y.5    Xiong, Y.6
  • 27
    • 0030929534 scopus 로고    scopus 로고
    • Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR
    • Perry A, Nobori T, Ru N etal. Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR. J Neuropathol Exp Neurol 1997; 56: 999-1008.
    • (1997) J Neuropathol Exp Neurol , vol.56 , pp. 999-1008
    • Perry, A.1    Nobori, T.2    Ru, N.3
  • 28
    • 80755159100 scopus 로고    scopus 로고
    • Molecular profile of oligodendrogliomas in young patients
    • Suri V, Jha P, Agarwal S etal. Molecular profile of oligodendrogliomas in young patients. Neuro Oncol 2011; 13: 1099-1106.
    • (2011) Neuro Oncol , vol.13 , pp. 1099-1106
    • Suri, V.1    Jha, P.2    Agarwal, S.3
  • 29
    • 0029587551 scopus 로고
    • Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
    • Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83: 993-1000.
    • (1995) Cell , vol.83 , pp. 993-1000
    • Quelle, D.E.1    Zindy, F.2    Ashmun, R.A.3    Sherr, C.J.4
  • 30
    • 0035013213 scopus 로고    scopus 로고
    • The INK4A/ARF locus: role in cellcycle control and apoptosis and implications for glioma growth
    • Ivanchuk SM, Mondal S, Dirks PB, Rutka JT. The INK4A/ARF locus: role in cellcycle control and apoptosis and implications for glioma growth. J Neurooncol 2001; 51: 219-229.
    • (2001) J Neurooncol , vol.51 , pp. 219-229
    • Ivanchuk, S.M.1    Mondal, S.2    Dirks, P.B.3    Rutka, J.T.4
  • 31
    • 0034649787 scopus 로고    scopus 로고
    • Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities
    • Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 2000; 60: 417-424.
    • (2000) Cancer Res , vol.60 , pp. 417-424
    • Ichimura, K.1    Bolin, M.B.2    Goike, H.M.3    Schmidt, E.E.4    Moshref, A.5    Collins, V.P.6
  • 32
    • 0029884472 scopus 로고    scopus 로고
    • Infrequent alterations of the p15,p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors
    • Sato K, Schäuble B, Kleihues P, Ohgaki H. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors. Int J Cancer 1996; 66: 305-308.
    • (1996) Int J Cancer , vol.66 , pp. 305-308
    • Sato, K.1    Schäuble, B.2    Kleihues, P.3    Ohgaki, H.4
  • 33
    • 0032801035 scopus 로고    scopus 로고
    • Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
    • Bigner SH, Matthews MR, Rasheed BK etal. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 1999; 155: 375-386.
    • (1999) Am J Pathol , vol.155 , pp. 375-386
    • Bigner, S.H.1    Matthews, M.R.2    Rasheed, B.K.3
  • 34
    • 0033767164 scopus 로고    scopus 로고
    • CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas
    • Bortolotto S, Chiadò-Piat L, Cavalla P etal. CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas. Int J Cancer 2000; 88: 554-557.
    • (2000) Int J Cancer , vol.88 , pp. 554-557
    • Bortolotto, S.1    Chiadò-Piat, L.2    Cavalla, P.3
  • 35
    • 84881312974 scopus 로고    scopus 로고
    • CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry
    • Purkait S, Jha P, Sharma MC etal. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry. Neuropathology 2013; 33: 405-412.
    • (2013) Neuropathology , vol.33 , pp. 405-412
    • Purkait, S.1    Jha, P.2    Sharma, M.C.3
  • 36
    • 0031906358 scopus 로고    scopus 로고
    • Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas
    • Burns KL, Ueki K, Jhung SL, Koh J, Louis DN. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas. J Neuropathol Exp Neurol 1998; 57: 122-130.
    • (1998) J Neuropathol Exp Neurol , vol.57 , pp. 122-130
    • Burns, K.L.1    Ueki, K.2    Jhung, S.L.3    Koh, J.4    Louis, D.N.5
  • 37
    • 77956222562 scopus 로고    scopus 로고
    • Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer
    • Sauvageau M, Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell 2010; 7: 299-313.
    • (2010) Cell , vol.7 , pp. 299-313
    • Sauvageau, M.1    Sauvageau, G.2
  • 38
    • 0028034775 scopus 로고
    • Transcriptional repression of the d-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb
    • Li Y, Nichols MA, Shay JW, Xiong Y. Transcriptional repression of the d-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54: 6078-6082.
    • (1994) Cancer Res , vol.54 , pp. 6078-6082
    • Li, Y.1    Nichols, M.A.2    Shay, J.W.3    Xiong, Y.4
  • 39
    • 0032541623 scopus 로고    scopus 로고
    • Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
    • Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 1998; 395: 237-243.
    • (1998) Nature , vol.395 , pp. 237-243
    • Russo, A.A.1    Tong, L.2    Lee, J.O.3    Jeffrey, P.D.4    Pavletich, N.P.5
  • 40
    • 84892426861 scopus 로고    scopus 로고
    • Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
    • Nakagawa S, Sakamoto Y, Okabe H etal. Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells. Oncol Rep 2014; 31: 983-988.
    • (2014) Oncol Rep , vol.31 , pp. 983-988
    • Nakagawa, S.1    Sakamoto, Y.2    Okabe, H.3
  • 41
    • 84871841675 scopus 로고    scopus 로고
    • Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
    • Qi W, Chan H, Teng L etal. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci U S A 2012; 109: 21360-21365.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 21360-21365
    • Qi, W.1    Chan, H.2    Teng, L.3
  • 42
    • 84867401194 scopus 로고    scopus 로고
    • Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
    • Kikuchi J, Takashina T, Kinoshita I etal. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer 2012; 78: 138-143.
    • (2012) Lung Cancer , vol.78 , pp. 138-143
    • Kikuchi, J.1    Takashina, T.2    Kinoshita, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.